JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M002785200 on April 18, 2000

J. Biol. Chem., Vol. 275, Issue 26, 19839-19843, June 30, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/26/19839    most recent
M002785200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nelson, K. L.
Right arrow Articles by Buckley, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nelson, K. L.
Right arrow Articles by Buckley, J. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Channel Formation by the Glycosylphosphatidylinositol-anchored Protein Binding Toxin Aerolysin Is Not Promoted by Lipid Rafts*

Kim L. Nelson and J. Thomas BuckleyDagger

From the Department of Biochemistry and Microbiology, University of Victoria, Box 3055, Victoria, British Columbia V8W 3P6, Canada

Received for publication, April 3, 2000, and in revised form, April 18, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Glycosylphosphatidylinositol-anchored proteins may be concentrated in membrane microdomains (lipid rafts) that are also enriched in cholesterol and sphingolipids. The glycosyl anchor of these proteins is a specific, high affinity receptor for the channel-forming protein aerolysin. We wished to determine if the presence of rafts promotes the activity of aerolysin. Treatment of T lymphocytes with methyl-beta -cyclodextrin, which destroys lipid rafts by sequestering cholesterol, had no measurable effect on the sensitivity of the cells to aerolysin; nor did similar treatment of erythrocytes decrease the rate at which they were lysed by the toxin. We also studied the rate of aerolysin-induced channel formation in liposomes containing glycosylphosphatidylinositol-anchored placental alkaline phosphatase, which we show is a receptor for aerolysin. In liposomes containing sphingolipids as well as glycerophospholipids and cholesterol, most of the enzyme was Triton X-100-insoluble, indicating that it was localized in rafts, whereas in liposomes prepared without sphingolipids, all of the enzyme was soluble. Aerolysin was no more active against liposomes containing rafts than against those that did not. We conclude that lipid rafts do not promote channel formation by aerolysin.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The possibility that lateral phase separations of specific bilayer components might lead to the occurrence of microdomains in cell membranes has received a great deal of recent attention (1-4). These "lipid rafts" are largely defined by their resistance to extraction with nonionic detergents (5-7). They are enriched in sphingolipids and cholesterol as well as in a number of membrane proteins, including several signal-transducing molecules and glycosylphosphatidylinositol (GPI)1-anchored proteins (7-11). Some members of this latter group of proteins are themselves involved in cell signaling, while some are enzymes and others have less well defined functions (12-16).

The channel-forming protein toxin aerolysin and its inactive precursor proaerolysin have the unique ability to bind specifically and with high affinity to GPI-anchored proteins on the surfaces of target cells (17-20). Once bound, proaerolysin may be converted to aerolysin by surface proteases (21). Bound aerolysin then forms heptameric oligomers that can insert into the plasma membrane, producing discrete channels (22). Because binding effectively concentrates the toxin on the cell surface, promoting oligomerization, cells that display GPI-anchored proteins are far more sensitive to aerolysin than those that do not (23, 24). Thus, normal T lymphocytes, which contain several GPI-anchored proteins that bind aerolysin, including Thy-1, are killed by 1-h exposure to 10-10 M aerolysin or proaerolysin, whereas T lymphocytes that lack GPI-anchored proteins because they are unable to synthesize the anchor are approximately 104-fold less sensitive. Similarly, we have shown that channel formation in artificial lipid bilayers occurs at far lower aerolysin concentrations if the bilayers contain incorporated GPI-anchored proteins, such as Thy-1 from brain or lymphocytes, or the erythrocyte aerolysin receptor, a novel aerolysin-binding GPI-anchored protein purified from erythrocytes (17, 18).

Recently, it has been proposed that lipid rafts promote channel formation by aerolysin because the increased density of GPI-anchored proteins therein leads to higher toxin concentrations than elsewhere on the cell surface, thereby, it was argued, increasing the rate of oligomerization (25). However, only circumstantial evidence was presented to support the proposal. It was shown that aerolysin comigrates with the Triton X-100-insoluble fraction upon density gradient centrifugation, which is consistent with the fact that GPI-anchored proteins also tend to migrate there, and with our observation that aerolysin binds these proteins with high affinity (17-20). It was also shown that treating cells with a cholesterol-lowering agent, which is known to lower the amount of GPI-anchored protein that is detergent-insoluble, also lowered the amount of detergent-insoluble aerolysin (25). Surprisingly, however, no comparison was made of the rate of channel formation by the toxin in the normal and treated cells.

Although it is possible that the concentration of GPI-anchored proteins in rafts might promote oligomerization of aerolysin, rafts could conceivably have the opposite effect. These regions are thought to be enriched in saturated lipids, so that the lateral mobility of GPI-anchored proteins may actually be lower when they are in rafts than when they are in the bulk of the membrane (2, 3). Restricted motion of bound aerolysin would tend to lower oligomerization rates. In any case, whether or not aerolysin binding to raft-associated GPI-anchored proteins does affect the kinetics of oligomerization of the toxin, it seems unlikely that there would be a significant change in the overall rate of channel formation. This is because binding rather than oligomerization is the rate-limiting step in channel formation, especially at low toxin concentrations (26), so that any influence of lipid rafts on oligomerization would probably be masked.

In the present study, we looked for direct evidence of an effect of lipid rafts on channel formation by aerolysin. Cell sensitivity to the toxin was compared before and after treatment with methyl-beta -cyclodextrin, which abolishes lipid rafts by reducing plasma membrane cholesterol levels (27). We found that the sensitivity of a T cell line was unaffected by cholesterol extraction; nor was the sensitivity of erythrocytes decreased by cholesterol removal. We also studied liposomes containing incorporated GPI-anchored placental alkaline phosphatase (PLAP), which we show acts as an aerolysin receptor. Liposomes containing PLAP associated with rafts were no more sensitive to aerolysin than liposomes that were raft-free.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- Liver phosphatidylcholine (PC) and phosphatidylethanolamine (PE) and brain sphingomyelin (SM) were obtained from Avanti Polar Lipids. Cholesterol and a crude preparation of human placental alkaline phosphatase were purchased from Sigma. Proaerolysin and the inactive variant Y221G were purified as described previously. The purified variant was labeled with the fluorescent probe Alexa 488 (Molecular Probes, Inc., Eugene, OR), using a procedure provided by the manufacturer.

Cell Culture-- The murine lymphocyte cell line EL4 was generously provided by Dr. R. Hyman (Salk Institute). Cells were grown in Dulbecco's modified Eagle's high glucose medium (DMEM) supplemented with bovine fetal clone I serum (10%, v/v), streptomycin (100 µg/ml), and penicillin (100 units/ml) with 5% CO2 at 37 °C.

Cholesterol Extraction with Methyl-beta -cyclodextrin-- EL4 cells at 2 × 106 cells/ml were washed twice in neat DMEM and then incubated with or without 10 mM methyl-beta -cyclodextrin in DMEM for 30 min at 37 °C, rotating end over end. Following extraction, half of the cells were washed twice in DMEM and used in the cytotoxicity assay and for flow cytometry; the other half were washed twice in PBS, and then a cholesterol determination (Cholesterol 20; Sigma) was performed on them.

Measurement of Detergent-insoluble Material-- Lymphocytes (1 ml of 2 × 107 cells/ml in DMEM, 0.5% bovine serum albumin) were incubated with 10-8 M Y221G proaerolysin on ice for 1 h. We used the proaerolysin variant here because it can bind as well as native proaerolysin but does not cause cell death, since it cannot form functional channels. Following incubation, the cells were washed twice in PBS and then extracted with 500 µl of 25 mM Tris, pH 7.5, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100 (w/v), containing a protease inhibitor mixture (1 mM phenylmethylsulfonyl fluoride, 2 µg/ml aprotinin, 2.2 µg/ml leupeptin, and 1 µg/ml pepstatin) for 30 min on ice. In some experiments, the detergent extraction step was carried out first; then 10-8 M Y221G was added to the cells, and the mixture was incubated for 15 min at 4 °C. Mixtures were adjusted to 1.5 M sucrose and overlaid with 8 ml of 1.2 M sucrose, 10 mM Tris, pH 7.4, followed by 2.5 ml of 0.15 M sucrose, 10 mM Tris, pH 7.4. The samples were then centrifuged in an SW41 rotor at 38,000 rpm for 18 h at 4 °C. Fractions of 1 ml were collected, and sample buffer was added for SDS-PAGE. Material at the bottoms of the centrifuge tubes was suspended directly in sample buffer.

The detergent solubility of lymphocyte Thy-1 was determined by simply measuring pelleting after detergent extraction (8). Cells were lysed by exposure to 1% (w/v) Triton X-100 in PBS with protease inhibitors for 15 min on ice as above. This was followed by centrifugation in a TA100.2 rotor (Beckman) at 75,000 rpm at 4 °C for 30 min. Protein was precipitated from the supernatant and the resuspended pellet with trichloroacetic acid (10%, w/v), and Thy-1 was detected by sandwich Western blotting.

The detergent insolubility of PLAP incorporated into liposomes was also measured by centrifugation. Liposomes (100 nmol of lipid) were pelleted at 75,000 rpm at 4 °C for 20 min in a TA100.2 rotor, and the pellet was resuspended in 450 µl of 0.1% Triton X-100 in 20 mM HEPES, 0.15 M NaCl, pH 7.4, and extracted on ice for 15 min. After centrifuging at 75,000 rpm at 4 °C for 30 min, the enzyme activity was measured in the supernatant and in the pellet resuspended in the same buffer.

Cell Viability Assay-- Lymphocytes at 106 cells/ml, treated with or without 10 mM methyl-beta -cyclodextrin as above, were incubated with a range of proaerolysin concentrations for 1 h at 37 °C under 5% CO2. Both 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium and phenazine methosulfate were then added to final concentrations of 333 and 7.66 µg/ml, respectively. The samples were incubated at 37 °C with 5% CO2 for 4 h, after which the A490 was measured as described previously (23).

Measurement of Aerolysin-induced Hemolysis-- Human erythrocytes were treated with 3.5 mM methyl-beta -cyclodextrin or PBS alone and then washed with PBS. Activated aerolysin was added to a final concentration of 5 nM in stirred cuvettes containing 1.5 ml of 0.8% (v/v) washed cells in PBS. The rate of hemolysis was monitored by measuring the decrease in optical density of the erythrocyte suspensions at 600 nM and 37 °C as a function of time. Readings were made using a Varian Cary I recording spectrophotometer as described previously (24).

The aerolysin concentration dependence of rat erythrocyte hemolysis was determined as described previously (28).

Flow Cytometry-- Control cells and cells that had been treated with methyl-beta -cyclodextrin for 30 min at 37 °C were exposed to 10-8 M Alexa 488-labeled Y221G proaerolysin for 30 min on ice. They were then washed twice with PBS and analyzed by flow cytometry.

PLAP Purification-- Twenty-five mg of human PLAP were dissolved in 50 ml of 1% Triton X-114 in PBS containing 1 mM phenylmethylsulfonyl fluoride by incubating for 20 min on ice. The extract was separated into detergent-rich and aqueous phases by warming the sample to 37 °C for 10 min and then centrifuging in a JA17 rotor (Beckman) for 10 min at 10,000 rpm and 23 °C. The detergent-rich phase was cooled and diluted back to 1% Triton X-114 by adding cold 20 mM HEPES, pH 7.4. Following warming and centrifuging to separate the phases once more, protein was precipitated from the detergent-rich phase by adding 5 volumes of acetone at -20 °C and incubating on ice for 30 min and then centrifuging at 5000 rpm for 30 min at 0 °C in a JA17 rotor. The acetone was decanted, and the pellet was dried for 2 h under vacuum. The dried pellet was resuspended in 20 mM HEPES, pH 7.4, containing 1% octyl glucoside, and applied to a DEAE column equilibrated in the same buffer. The column was eluted with a salt gradient of 0-0.5 M NaCl in 20 mM HEPES, pH 7.4, 1% octyl glucoside. Enzyme activity, which was assayed using a standard alkaline phosphatase assay (Sigma), appeared at approximately 0.18 M salt. Silver staining after SDS-polyacrylamide gel electrophoresis produced a single band accounting for more than 95% of applied material. The purified protein had a specific activity of approximately 400 units/mg, slightly less than the specific activity reported previously for purified alkaline phosphatase lacking the GPI anchor (29).

Liposome Preparation-- Lipid films containing 12 µmol of total lipid in the proportions 5 PC:3 PE:3 CH, 3 PC:3 PE:3 CH:2 SM, 4 PC:3 PE:3 CH, and 3 PC:3 PE:3 CH:1 SM, were dried under nitrogen. Dried films were desiccated overnight and then each rehydrated in 2 ml of 20 mM HEPES, 0.15 M NaCl, 100 mM carboxyfluorescein, pH 7.4. Liposomes containing sphingomyelin were rehydrated at 45 °C, while the others were rehydrated at room temperature. Liposomes were rapidly frozen (-70 °C acetone bath) and thawed (45 °C water bath) six times. After freeze thawing, liposomes were passed through a 0.4-µm polycarbonate filter (Nucleopore) six times, using a Lipex Biomembrane extruder. The sphingomyelin liposomes were extruded at 45 °C, and the others were extruded at room temperature. Lipid phosphorous was measured according to a published procedure (30). Vesicle size was determined using a Nicomp Submicron particle sizer.

Reconstitution of PLAP into Liposomes-- To determine optimum octyl glucoside concentrations for incorporation of GPI-anchored proteins into liposomes, a published method was used (31). The turbidity of liposomes at 450 nm was monitored while increasing the concentration of octyl glucoside until the absorbance at 450 nm began to drop. This detergent concentration (20 mM for 4 PC:3 PE:3 CH, 21 mM for 3 PC:3 PE:3 CH:1 SM, 23 mM for 5 PC:3 PE:3 CH, and 30 mM for 3 PC:3 PE:3 CH:2 SM liposomes) was chosen for GPI-anchored protein incorporation. 9.5 µg of PLAP was incubated with 500 µl of 1.3 mM lipid. This mixture was dialyzed overnight against 20 mM HEPES, 0.15 M NaCl pH7.4 at 4 °C (5 PC:3 PE:3 CH and 4 PC:3 PE:3 CH liposomes), or 22 °C (sphingomyelin-containing liposomes) to remove detergent and free carboxyfluorescein. Liposomes were then passed over a Sephacryl S-300 column (23 ml) in 20 mM HEPES, 0.15 M NaCl, to remove unincorporated PLAP and free dye. Phosphorous assays were performed on liposomes collected off of the column.

Liposome Release Assay-- Carboxyfluorescein release was measured at 37 °C using a Photon Technology spectrofluorimeter. The excitation wavelength was set at 490 nm, and the emission wavelength was set at 520 nm. A 5-nm slit width was used for both monochromators. Aliquots of liposome preparations (0.26 nmol of lipid) were added to 3 ml of 20 mM HEPES, 0.15 M NaCl, pH 7.4. Activated aerolysin was added to a final concentration of 36 nM at 1 min.

Detection of Proteins by Sandwich Western Blotting-- Samples were separated by SDS-polyacrylamide gel electrophoresis (32) and blotted. Blots were probed with proaerolysin, followed by polyclonal anti-aerolysin and anti-rabbit horseradish peroxidase according to our published procedure (18). They were then developed by enhanced chemiluminescence (Amersham Pharmacia Biotech).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Some Aerolysin Is Recovered in a Detergent-insoluble Cell Fraction-- One of the few easily measured properties of lipid rafts is their insolubility in some nonionic detergents (5, 7). The raft lipids and proteins are thought to remain associated in Triton X-100, and the insoluble complexes can be separated from other cell components by flotation in sucrose density gradients (5). Since proaerolysin binds very tightly with GPI-anchored proteins, which partially associate with the insoluble complexes, some proaerolysin should be found in the floating fraction after extraction of cells that have been pretreated with the protein. Such an association was first reported using baby hamster kidney cells and presented as evidence that rafts favor channel formation by aerolysin (25). The results in Fig. 1A show that detergent extraction of EL4 cells pretreated with proaerolysin also led to a detergent-insoluble fraction, corresponding to rafts, that contained some of the protoxin. Not all of the protein was recovered with the floating fraction. Some remained at the bottom of the centrifuge tube, indicating that it was extracted with detergent and therefore not raft-associated. A similar distribution of the GPI-anchored protein Thy-1 was observed (data not shown). This is consistent with the generally held view that only a fraction of the plasma membrane's GPI-anchored proteins are localized in rafts at any given time. It was not possible to make a direct comparison of our results with those obtained with baby hamster kidney cells, since in that study gradient fractions were normalized to constant total protein, thereby heavily weighting the amount of aerolysin apparently associated with the floating fraction in the SDS-polyacrylamide gels (25).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 1.   Aerolysin is partly recovered in a detergent-insoluble fraction when added before or after cell disruption with Triton X-100. A, EL4 cells were incubated with 10-8 M Y221G and then extracted with Triton X-100 as described under "Experimental Procedures." B, cells were extracted with detergent and then 10-8 M Y221G aerolysin was added.

The fact that detergent extraction of cells that had been incubated with aerolysin resulted in the recovery of some of the toxin in a detergent-insoluble fraction is not necessarily evidence that there is a real and physiologically significant association of the toxin with rafts in situ. Thus, when aerolysin was added after the cells had been disrupted with Triton X-100, the amount recovered in the low density detergent-insoluble fraction did not differ very much from the amount recovered in this fraction when the cells had been preincubated with the toxin before extraction (Fig. 1, compare A and B).

Raft Depletion by Cholesterol Extraction Does Not Affect Channel Formation in Lymphocytes-- There is considerable evidence that the detergent-insoluble fraction, or lipid rafts, can be greatly reduced by lowering the cholesterol content of the membrane. This can be accomplished by treating cells with the cholesterol-sequestering agent methyl-beta -cyclodextrin (27). Extraction of EL4 cells with 10 mM methyl-beta -cyclodextrin for 30 min led to a 45% decline in cholesterol levels and a striking change in the amount of Thy-1 detected in the detergent-insoluble fraction (data not shown), evidence that rafts had been greatly reduced. Flow cytometric analysis of the treated and control cells using a fluorescently labeled toxin indicated that cholesterol extraction had little or no effect on aerolysin binding (Fig. 2). This was not surprising, since there is no reason to believe that there should be any difference in the binding of the protein to GPI-anchored proteins whether they are located in rafts or distributed on the rest of the membrane surface. More importantly, the results in Fig. 3 show that the depleted cells, containing considerably less cholesterol and detergent-insoluble GPI-anchored protein, were no less sensitive to the toxin than the untreated cells.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 2.   Raft reduction has no effect on the binding of aerolysin to lymphocytes. Flow cytometry analysis of binding of fluorescently labeled aerolysin to untreated T lymphocytes (solid line) and lymphocytes treated with 10 mM methyl-beta -cyclodextrin (dotted line).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 3.   Raft reduction does not affect the sensitivity of T lymphocytes to aerolysin. Cell viability was determined before (open circle ) and after () raft disruption by methyl-beta -cyclodextrin. Also shown is the sensitivity of untreated rat erythrocytes to aerolysin (diamond ). The percentage of cell lysis of erythrocytes was determined spectrophotometrically as described previously (28). Lymphocyte cell viability was measured as described under "Experimental Procedures."

Cholesterol Depletion Does Not Decrease the Sensitivity of Erythrocytes to Aerolysin-- We also studied the effect of cholesterol depletion on the sensitivity of human erythrocytes. Erythrocytes are lysed by aerolysin at concentrations similar to those that kill EL4 cells (Fig. 3), although they contain different aerolysin-binding GPI-anchored proteins. This too is not surprising, since aerolysin binds to the anchor, which has a constant core structure from cell to cell and species to species. Treatment with 3.5 mM methyl-beta -cyclodextrin for 60 min removed 90% of the erythrocyte cholesterol, a higher percentage than is removed from other cell types, presumably because erythrocyte cholesterol is entirely associated with the plasma membrane. Remarkably, the nearly complete extraction of the steroid from the cells did not lower the rate at which they were lysed by aerolysin (Fig. 4), despite the fact that the amount of raft-associated GPI-anchored protein, if any, must have been very small.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 4.   Erythrocytes do not become less sensitive to aerolysin following cholesterol extraction. Kinetic analysis of aerolysin-induced hemolysis of control erythrocytes (solid line) and erythrocytes treated with 3.5 mM methyl-beta -cyclodextrin (hatched line) is shown.

Rafts in Liposomes Do Not Promote Channel Formation-- The above results lend no support to the idea that lipid rafts have an important role to play in channel formation by aerolysin. However, although it seemed unlikely that the erythrocytes used to obtain the data in Fig. 4 could contain any significant raft population after extraction of 90% of their cholesterol, we could not exclude the possibility that a small raft population remained. In order to compare membranes totally lacking rafts with membranes that contain a detergent-soluble fraction, we decided to use large unilamellar vesicles containing a GPI-anchored protein that acts as an aerolysin receptor. We have previously shown that Thy-1 is an excellent receptor for aerolysin when it is incorporated into liposomes; however, for the present study we wished to use a protein that could be more easily quantitated, so we first determined if GPI-anchored placental alkaline phosphatase could substitute for Thy-1. The results in Fig. 5A show that the addition of 36 nM aerolysin to liposomes containing incorporated PLAP resulted in rapid dye release, whereas liposomes without PLAP were not affected by this concentration of the toxin. We obtained a very similar pattern with liposomes containing incorporated Thy-1 (18).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 5.   Liposomes containing PLAP in rafts are not more sensitive to aerolysin than liposomes lacking rafts. A, the rates of dye release from 3 PC:3 PE:3 CH:1 SM liposomes (moderate raft-associated PLAP) and 4 PC:3 PE:3 CH liposomes, lacking rafts, were virtually identical (solid and dotted lines at the top). The flat dotted curve at the bottom was obtained with PLAP-free 3 PC:3 PE:3 CH:1 SM liposomes. The PLAP liposomes containing sphingomyelin were 216 nm in diameter, while those lacking sphingomyelin were 157 nm. B, aerolysin sensitivity of 3 PC:3 PE:3 CH:2 SM (high raft-associated PLAP; dotted line) and raft-free 5 PC:3 PE:3 CH liposomes (solid line). Liposomes containing sphingomyelin were 145 nm in diameter, while those lacking sphingomyelin were 195 nm in diameter. Both liposome preparations contained 1 receptor/1850 nm2 of exterior lipid surface. All liposomes were treated with 36 nM aerolysin at room temperature as described under "Experimental Procedures." These results are representative of several experiments. Similar results were obtained at 37 °C.

Having shown that PLAP is an aerolysin receptor, we then incorporated the enzyme into liposomes of different lipid compositions. Most of the PLAP in the 3:3:3:2 (PC:PE:CH:SM) vesicles was detergent-insoluble, evidence for the presence of rafts, whereas all of the enzyme in liposomes lacking SM was soluble in Triton X-100. Vesicles made with half as much SM had approximately half as much detergent-insoluble PLAP (data not shown). The ability to prepare liposomes with and without rafts allowed us to determine directly whether or not these lipid structures have any pronounced effect on aerolysin sensitivity. The rates of channel formation by aerolysin were next compared in liposomes lacking raft-associated PLAP or containing moderate (Fig. 5A) or large amounts (Fig. 5B) of the detergent-insoluble enzyme. It may be seen that there were only minor differences in the rate of dye release regardless of the liposome composition. Release from the liposomes containing large amounts of raft PLAP was actually somewhat slower than from the corresponding liposomes lacking sphingomyelin (Fig. 5B). The two liposome populations contained very similar proportions of PLAP to lipid, although the SM-containing population was somewhat smaller. Comparable results were obtained when lower concentrations of aerolysin were used (data not shown).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Although the results in this paper cast no direct light on the existence or significance of lipid rafts in cell membranes, they clearly show that if these structures exist, they have little or no influence on the rate of channel formation by aerolysin, either in whole cells or in liposomes. The result is not surprising for two reasons. First, even if rafts did alter the rate of aerolysin oligomerization, we would not expect to see an effect on cells unless oligomerization becomes the rate-limiting step in channel formation. Normally, binding is rate-limiting, and there is no reason to believe that GPI-anchored proteins clustered in rafts would bind the toxin any better than when they are distributed on the cell surface. In fact, the results in Fig. 2 show that binding is not affected by raft disruption. Second, it is not intuitively obvious that, even if oligomerization were the rate-limiting step in channel formation, it would occur more quickly if the receptors were clustered in rafts. Membrane GPI-anchored proteins could be less mobile when they occur in these regions, because of the increased levels of relatively saturated fatty acids found there (7). The reduced mobility could lower the rate of oligomerization of the bound toxin. In any case, GPI-anchored proteins are also located in the bulk of the lipid bilayer, where they are apparently very mobile, some have speculated even more mobile than transmembrane proteins (3, 14). They appear to simply pause in rafts as they move about the cell surface; at any given time, only a fraction is thought to be localized in rafts (3, 33).

The results we obtained with erythrocytes extracted with methyl-beta -cyclodextrin allow us to comment on the role of cholesterol in channel formation by aerolysin. There has been a recent report that aerolysin is inhibited when preincubated with cholesterol, which was taken as evidence that the toxin can interact with the steroid (34). Earlier we had shown that aerolysin is capable of forming channels in cholesterol-free liposomes, indicating that it has no absolute requirement for the steroid (35). Here we found that removing nearly all of the cholesterol from the cell did not lower the rate of channel formation. Thus, it would seem that cholesterol plays no significant role in the action of aerolysin.

In conclusion, the unusual ability of aerolysin to bind to GPI-anchored proteins may provide a new tool to study the chemistry and biology of lipid rafts, but there is no reason to believe that these structures are important in the process of channel formation by the toxin.

    ACKNOWLEDGEMENTS

We thank Félix Goñi and Alicia Alonzo for helpful discussions. The technical assistance of Ryan Barry is gratefully acknowledged.

    FOOTNOTES

* This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada and from the Medical Research Council of Canada.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 250-721-7081; Fax: 250-598-6877; E-mail: tbuckley@uvic.ca.

Published, JBC Papers in Press, April 18, 2000, DOI 10.1074/jbc.M002785200

    ABBREVIATIONS

The abbreviations used are: GPI, glycosylphosphatidylinositol; PLAP, placental alkaline phosphatase; PC, phosphatidylcholine; PE, phosphatidylethanolamine; CH, cholesterol; SM, sphingomyelin; DMEM, Dulbecco's modified Eagle's high glucose medium; PBS, phosphate-buffered saline.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Brown, D. A., and London, E. (1998) Annu. Rev. Cell Dev. Biol. 14, 111-136
2. Brown, D. A., and London, E. (1998) J. Memb. Biol. 164, 103-114
3. Jacobson, K., and Dietrich, C. (1999) Trends Cell Biol. 9, 87-91
4. Kurzchalia, T. V., and Parton, R. G. (1999) Curr. Opin. Cell Biol. 11, 424-431
5. Fra, A. M., Williamson, E., Simons, K., and Parton, R. G. (1994) J. Biol. Chem. 269, 30745-30748
6. Ostermeyer, A., Beckrich, B., Ivarson, K., Grove, K., and Brown, D. (1999) J. Biol. Chem. 274, 34459-34466
7. Schroeder, R., London, E., and Brown, D. A. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 12130-12134
8. Benting, J., Rietveld, A., Ansorge, I., and Simons, K. (1999) FEBS 462, 47-50
9. Friedrichson, T., and Kurzchalia, T. V. (1998) Nature 394, 802-805
10. Harder, T., and Simons, K. (1999) Eur. J. Immunol. 29, 556-562
11. Varma, R., and Mayor, S. (1998) Nature 394, 798-801
12. Brown, D. (1993) Curr. Opin. Immun. 5, 349-354
13. Janes, P. W., Ley, S. C., and Magee, A. I. (1999) J. Cell Biol. 147, 447-461
14. McConville, M. J., and Ferguson, M. A. J. (1993) Biochem. J. 294, 305-324
15. Redman, C. A., Thomas-Oates, J. E., Ogata, S., Ikehara, Y., and Ferguson, M. A. (1994) Biochem. J. 302, 861-865
16. Roberts, W. L., Kim, B. H., and Rosenberry, T. L. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 7817-7821
17. Cowell, S., Wolfgang, A., Gruber, H. J., Nelson, K. L., and Buckley, J. T. (1997) Molec. Microbiol. 25, 343-350
18. Nelson, K. L., Raja, S. M., and Buckley, J. T. (1997) J. Biol. Chem. 272, 12170-12174
19. Diep, D. B., Nelson, K. L., Raja, S. M., Pleshak, E. N., and Buckley, J. T. (1998) J. Biol. Chem. 273, 2355-2360
20. MacKenzie, C. R., Hirama, T., and Buckley, J. T. (1999) J. Biol. Chem. 274, 22604-22609
21. Abrami, L., Fivaz, M., Decroly, E., Seidah, N. G., Jean, F., Thomas, G., Leppla, S. H., Buckley, J. T., and van der Goot, F. G. (1998) J. Biol. Chem. 273, 32656-32661
22. van der Goot, F. G., Pattus, F., Wong, K. R., and Buckley, J. T. (1993) Biochemistry 32, 2636-2642
23. Nelson, K. L., Brodsky, R. A., and Buckley, J. T. (1999) Cell. Micro. 1, 69-74
24. Brodsky, R. A., Mukhina, G., Nelson, K. L., Lawrence, T. S., Jones, R. J., and Buckley, J. T. (1999) Blood 93, 1749-1756
25. Abrami, L., and van der Goot, F. G. (1999) J. Cell Biol. 147, 175-184
26. Garland, W. J., and Buckley, J. T. (1988) Infect. Immun. 56, 1249-1253
27. Ilangumaran, S., and Hoessli, D. C. (1998) Biochem. J. 335, 433-440
28. Diep, D. B., Nelson, K. L., Lawrence, T. S., Sellman, B., Tweten, R. K., and Buckley, J. T. (1999) Molec. Microbiol. 31, 785-794
29. Chang, T. C., Huang, S. M., Huang, T. M., and Chang, G. G. (1992) Eur. J. Biochem. 209, 241-247
30. Bartlett, G. R. (1959) J. Biol. Chem. 234, 466-468
31. Nosjean, O., and Roux, N. (1999) Eur. J. Biochem. 263, 865-870
32. Neville, D. M. (1971) J. Biol. Chem. 246, 6328-6334
33. Sheets, E. D., Lee, G. M., Simson, R., and Jacobson, K. (1997) Biochemistry 36, 12449-12458
34. Ferguson, M. R, Xu, X. J., Houston, C. W., Peterson, J. W., Coppenhaver, D. H., Popov, V. L., and Chopra, A. K. (1997) Infect. Immun. 65, 4299-4308
35. Howard, S. P., and Buckley, J. T. (1982) Biochemistry 21, 1662-1667


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. Mandal, A. Mazumder, P. Das, M. Kundu, and J. Basu
Fas-, Caspase 8-, and Caspase 3-dependent Signaling Regulates the Activity of the Aminophospholipid Translocase and Phosphatidylserine Externalization in Human Erythrocytes
J. Biol. Chem., November 25, 2005; 280(47): 39460 - 39467.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Fukushima, Y. Ikehara, and K. Yamashita
Functional Role Played by the Glycosylphosphatidylinositol Anchor Glycan of CD48 in Interleukin-18-induced Interferon-{gamma} Production
J. Biol. Chem., May 6, 2005; 280(18): 18056 - 18062.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. S. Giddings, A. E. Johnson, and R. K. Tweten
Redefining cholesterol's role in the mechanism of the cholesterol-dependent cytolysins
PNAS, September 30, 2003; 100(20): 11315 - 11320.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Y. Fujii, T. Nomura, R. Yokoyama, S. Shinoda, and K. Okamoto
Studies of the Mechanism of Action of the Aerolysin-Like Hemolysin of Aeromonas sobria in Stimulating T84 Cells To Produce Cyclic AMP
Infect. Immun., March 1, 2003; 71(3): 1557 - 1560.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Miyata, J. Minami, E. Tamai, O. Matsushita, S. Shimamoto, and A. Okabe
Clostridium perfringensepsilon -Toxin Forms a Heptameric Pore within the Detergent-insoluble Microdomains of Madin-Darby Canine Kidney Cells and Rat Synaptosomes
J. Biol. Chem., October 11, 2002; 277(42): 39463 - 39468.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Petit, E. Maier, M. Gibert, M. R. Popoff, and R. Benz
Clostridium perfringens Epsilon Toxin Induces a Rapid Change of Cell Membrane Permeability to Ions and Forms Channels in Artificial Lipid Bilayers
J. Biol. Chem., May 4, 2001; 276(19): 15736 - 15740.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/26/19839    most recent
M002785200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nelson, K. L.
Right arrow Articles by Buckley, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nelson, K. L.
Right arrow Articles by Buckley, J. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.